STK11 and malignant endocrine neoplasm: Further analysis of additional ECM molecules, including VTN, EMC1, THBS3, and CLEC3B revealed a positive correlation trend with PEBP1/STK11 co-expression in endocrine cancers, while correlations in other cancer types varied, suggesting a context-dependent relationship (Figure 6C).